+44 7868 792050
Taha H Aldeen and Adebajo Adewale
Barnsley Hospital, UK
Posters & Accepted Abstracts: Clin Exp Dermatol Res
Psoriasis is no longer a skin problem; it is a chronic immune inflammatory condition associated with multiple comorbidities under the skin and up to a third of the patients develop psoriatic arthritis (PsA). The disease has been associated with obesity, dyslipidemia, diabetes mellitus, hypertension, cardiovascular diseases, stroke, cancer and mental distress or depression. There is no current cure for psoriasis and although the global prevalence of psoriasis is around 2% the disease incurs long term financial strain on the patient and on the health provider. International studies associated obesity with psoriasis incidence, severity and with diminish response to psoriasis systemic therapy. Clinical trials and bariatric surgery conducted on obese psoriasis patients showed that weight reduction can improve psoriasis and its associated comorbidities. We present a case report of morbidly obese diabetic patient who developed psoriasis after having bariatric surgery and review the association between psoriasis and obesity and the impact of weight reduction on obese psoriasis patients.
Taha H Aldeen is a Consultant Dermatologist and Honorary Senior Clinical Lecturer. He has published more than 16 papers in peer-reviewed journals.